Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

INTERCURE (INCR)

  • Technical Exchange News
  • March 05, 2026, 02:59 UTC
  • 3
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Ensysce Biosciences Inc. (ENSC)

  • Technical Exchange News
  • March 05, 2026, 02:59 UTC
  • 2
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Ventyx Biosciences (VTYX)

  • Technical Exchange News
  • March 05, 2026, 00:26 UTC
  • 3
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Ventyx Biosciences, Inc. - Common Stock. New value: Ventyx Biosciences, Inc. - Common Stock.

Comment Full text

Ventyx Biosciences (VTYX)

  • Technical Exchange News
  • March 05, 2026, 00:26 UTC
  • 3
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Ventyx Biosciences, Inc. - Common Stock.

Comment Full text

Ventyx Biosciences (VTYX)

  • Technical Exchange News
  • March 05, 2026, 00:26 UTC
  • 2
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Ventyx Biosciences, Inc. - Common Stock.

Comment Full text

Tenon Medical Inc (TNON)

  • Technical Exchange News
  • March 04, 2026, 18:42 UTC
  • 4
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

PDS Biotechnology Corporation (PDSB)

  • Technical Exchange News
  • March 04, 2026, 18:42 UTC
  • 4
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

INTERCURE (INCR)

  • Technical Exchange News
  • March 04, 2026, 18:42 UTC
  • 4
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Ensysce Biosciences Inc. (ENSC)

  • Technical Exchange News
  • March 04, 2026, 18:41 UTC
  • 4
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

RAPT Therapeutics Inc (RAPT)

  • Technical Exchange News
  • March 04, 2026, 09:03 UTC
  • 3
  • 0 comments

RAPT Therapeutics Inc (RAPT) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text
  • Previous
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next

Search

News categories

  • Technical Exchange News(11221)
  • Event(2606)
  • SEC News(198255)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(130820)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin